These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8808153)
1. Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice. Caputo FA; Ali SF; Wolff GL; Scallet AC Pharmacol Biochem Behav; 1996 Feb; 53(2):425-32. PubMed ID: 8808153 [TBL] [Abstract][Full Text] [Related]
2. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. Bergen HT; Mizuno TM; Taylor J; Mobbs CV Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456 [TBL] [Abstract][Full Text] [Related]
3. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla. Alessi NE; Quinlan P; Khachaturian H Peptides; 1988; 9(4):689-95. PubMed ID: 2852357 [TBL] [Abstract][Full Text] [Related]
4. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat. Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587 [TBL] [Abstract][Full Text] [Related]
5. Postnatal MSG treatment attenuates angiotensin II (AII) induced drinking in rats. Caputo FA; Scallet AC Physiol Behav; 1995 Jul; 58(1):25-9. PubMed ID: 7667423 [TBL] [Abstract][Full Text] [Related]
6. Neonatal treatment with monosodium glutamate does not alter grooming behavior induced by novelty or adrenocorticotropic hormone. Dunn AJ; Webster EL; Nemeroff CB Behav Neural Biol; 1985 Jul; 44(1):80-9. PubMed ID: 3010931 [TBL] [Abstract][Full Text] [Related]
7. Neonatal monosodium glutamate lesions alter neurosensitivity to ethanol in adult mice. Crabbe JC; Dorsa DM Pharmacol Biochem Behav; 1986 May; 24(5):1343-51. PubMed ID: 2941768 [TBL] [Abstract][Full Text] [Related]
8. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Itateyama E; Chiba S; Sakata T; Yoshimatsu H Exp Biol Med (Maywood); 2003 Nov; 228(10):1132-7. PubMed ID: 14610251 [TBL] [Abstract][Full Text] [Related]
9. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice. Dawson R; Lorden JF J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414 [TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated α-melanocyte-stimulating hormone overexpression in the hypothalamus decreases diet induced obesity in mice. Eerola K; Nordlund W; Virtanen S; Dickens AM; Mattila M; Ruohonen ST; Chua SC; Wardlaw SL; Savontaus M; Savontaus E J Neuroendocrinol; 2013 Dec; 25(12):1298-1307. PubMed ID: 24118213 [TBL] [Abstract][Full Text] [Related]
11. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Maiter D; Underwood LE; Martin JB; Koenig JI Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848 [TBL] [Abstract][Full Text] [Related]
12. Effects of ad libitum ingestion of monosodium glutamate on weight gain in C57BL6/J mice. Ren X; Ferreira JG; Yeckel CW; Kondoh T; de Araujo IE Digestion; 2011; 83 Suppl 1():32-6. PubMed ID: 21389726 [TBL] [Abstract][Full Text] [Related]
13. Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background. Smart JL; Low MJ Ann N Y Acad Sci; 2003 Jun; 994():202-10. PubMed ID: 12851317 [TBL] [Abstract][Full Text] [Related]
14. Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult. Dawson R; Callahan MF; Annau Z Pharmacology; 1986; 32(1):25-37. PubMed ID: 2418449 [TBL] [Abstract][Full Text] [Related]
15. Monosodium glutamate-induced reductions in hypothalamic beta-endorphin content result in mu-opioid receptor upregulation in the medial preoptic area. Desjardins GC; Brawer JR; Beaudet A Neuroendocrinology; 1992 Sep; 56(3):378-84. PubMed ID: 1331839 [TBL] [Abstract][Full Text] [Related]
17. Ontogenesis of proopiomelanocortin and its processing to beta-endorphin by the fetal and neonatal rat brain. Angelogianni P; Li HL; Gianoulakis C Neuroendocrinology; 2000 Oct; 72(4):231-41. PubMed ID: 11070427 [TBL] [Abstract][Full Text] [Related]
18. The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Plum L; Lin HV; Dutia R; Tanaka J; Aizawa KS; Matsumoto M; Kim AJ; Cawley NX; Paik JH; Loh YP; DePinho RA; Wardlaw SL; Accili D Nat Med; 2009 Oct; 15(10):1195-201. PubMed ID: 19767734 [TBL] [Abstract][Full Text] [Related]
19. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460 [TBL] [Abstract][Full Text] [Related]
20. β-endorphin differentially contributes to food anticipatory activity in male and female mice undergoing activity-based anorexia. Daimon CM; Hentges ST Physiol Rep; 2021 Mar; 9(5):e14788. PubMed ID: 33661571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]